Evolus (NASDAQ: EOLS) insider sells 13,669 shares to cover taxes

Rhea-AI Filing Summary

Evolus, Inc. director and officer David Moatazedi reported an open-market sale of 13,669 shares of common stock at a weighted average price of $4.7501 per share. According to the filing, the trades were executed under a Rule 10b5-1 trading plan and were required to cover tax withholding obligations from the settlement of restricted stock unit awards. After these transactions, Moatazedi directly holds 604,700 Evolus shares, indicating this was a relatively small, tax-driven adjustment to his overall equity position.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MOATAZEDI DAVID

(Last) (First) (Middle)

520 NEWPORT CENTER DR.

SUITE 1200

(Street)

NEWPORT BEACH CALIFORNIA 92660

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Evolus, Inc. [ EOLS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/20/2026		S(1)		13,669	D	$4.7501(2)	604,700	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the settlement of restricted stock unit awards.

2. The shares were sold in multiple trades at prices ranging from $4.7498 to $4.775. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

President & Chief Executive Officer

	/s/ Jeffrey J. Plumer, as attorney-in-fact for David Moatazedi	03/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Evolus (EOLS) report for David Moatazedi?

Evolus reported that director and officer David Moatazedi sold 13,669 shares of common stock. The sale was disclosed on a Form 4 and reflects an open-market transaction executed under a pre-arranged Rule 10b5-1 trading plan tied to RSU tax obligations.

At what price did David Moatazedi sell Evolus (EOLS) shares?

Moatazedi’s Evolus shares were sold at a weighted average price of $4.7501 per share. The filing notes multiple trades occurred in a price range from $4.7498 to $4.775, with the exact breakdown available upon request from the reporting person.

How many Evolus (EOLS) shares does David Moatazedi hold after this Form 4 sale?

After selling 13,669 shares, Moatazedi directly holds 604,700 shares of Evolus common stock. This indicates the reported transaction is small relative to his remaining stake, and primarily reflects shares sold to address related tax withholding obligations.

Was the Evolus (EOLS) insider sale by David Moatazedi discretionary or pre-planned?

The sale was carried out under a Rule 10b5-1 trading plan adopted by Moatazedi. Such plans pre-schedule trades in advance, meaning the timing is predetermined and the transaction is more routine than a fully discretionary insider sale.

Why did David Moatazedi sell Evolus (EOLS) shares according to the Form 4?

The Form 4 states the shares were sold to cover tax withholding obligations from the settlement of restricted stock unit awards. This type of sale is typically mechanistic, reflecting tax requirements rather than a change in the insider’s fundamental view of the company.